In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aesculap AG

Division of B. Braun Melsungen AG
www.aesculap.com

Latest From Aesculap AG

Market Intel: Orthobiologics Market Well-Positioned For Innovative Reconstruction

Global sales of orthobiologics for musculoskeletal soft tissue replacement and regeneration are predicted to hit $1.4bn by 2021, driven largely by rising numbers of sports injuries requiring treatment, but also by a higher prevalence of osteoarthritis and a need for innovative treatments for musculoskeletal repair. This article offers an in-depth look at the orthobiologics market landscape for cartilage, meniscus and ligament/tendon replacement and regeneration, as well as insight from an orthopedic surgeon. It also analyzes key players in these markets and highlights emerging trends and the greatest barriers for wider adoption of products.

Orthopedics Cellular & Genetic

Teleflex Bets Percutaneous Laparoscopy Will Be MIS Game Changer

Story and Podcast: Teleflex Medical launched in March a novel portfolio of miniaturized percutaneous surgical instruments that have the same functionality as full-sized laparoscopic instruments, but allow surgeons to access the abdominal cavity using trocar-less entry and much smaller incisions than those required in traditional laparoscopy. Teleflex execs say the technology is a game changer, and the company hopes percutaneous laparoscopy will become the standard of care for the 4 million laparoscopic procedures performed annually in the US.

Medical Device Innovation

Arthroplasty Physicians Trade Views If Not Blows At World Congress

It was more knees than hips, on balance, but the inaugural World Arthroplasty Congress in mid-April brought surgeons from all parts of the world to Paris for three days of discussions, presentations, and discoveries. It was clear at the well-attended event that orthopedic physicians don’t all see eye-to-eye in a sector undergoing rapid change.

Medical Device Surgical Procedures

MIS Trends 2014: Improving Visualization

Innovation is driving healthy growth in the multibillion-dollar market for minimally invasive surgical products as manufacturers develop new laparoscopic visualization systems and advanced surgical tools with robotic-like features designed to enable more complex procedures to be performed via a minimally invasive approach.

Medical Device Asia Pacific
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Aesculap AG & Co. KG
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • B. Braun Melsungen AG
  • Senior Management
  • Contact Info
  • Aesculap AG
    Phone: (49) 7461 95 0
    Am AESCULAP-Platz
    P.O. Box 40 Tuttlingen, D-78532
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register